Mar
04
2021
Final steps for Soberana 02, the first Latin American vaccine against coronavirus
"In the second half of the year, we will be able to immunise the entire population, and also provide doses to the countries that require it," says director of Science and Innovation at Cuban state company BioCubaFarma, Rolando Pérez Rodríguez, interviewed here by Pagina 12.
A few days after starting the last phase of the clinical trial of Soberana 02, which has all the cards to be the first fully developed vaccine in Latin America, the Cuban scientific community confirmed that it expects a production of 100 million doses for this year.
